nach oben

Erschienen in:

15.09.2016 | Review

A critical overview of long non-coding RNA in glioma etiology 2016: an update

verfasst von: Yuan-Feng Gao, Zhi-Bin Wang, Tao Zhu, Chen-Xue Mao, Xiao-Yuan Mao, Ling Li, Ji-Ye Yin, Hong-Hao Zhou, Zhao-Qian Liu

Erschienen in: Tumor Biology | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

With the development of whole genome and transcriptome sequencing technologies, a growing body of long non-coding RNAs (lncRNAs) has been identified and is receiving increasing attention. LncRNAs are non-protein encoding transcripts whose functions are crucial for advancing our comprehensive understanding of biological processes in human health and diseases, specifically glioma. It has been established that lncRNAs are differently expressed in the central nervous system and may play a vital role in glioma. As of June 2016, 20 lncRNAs have been identified that may play a role in glioma pathogenesis. Investigation into the role of lncRNAs in glioma may help to identify potential biomarkers which can improve the diagnosis and treatment of glioma. In this paper, we review current understanding of the function of lncRNAs in glioma initiation and progression.

Lino MM, Merlo A, Boulay JL. Notch signaling in glioblastoma: a developmental drug target? BMC Med. 2010;8:72. doi:10.1186/1741-7015-8-72.CrossRefPubMedPubMedCentral

Altieri R, Agnoletti A, Quattrucci F, Garbossa D, Calamo Specchia FM, Bozzaro M, et al. Molecular biology of gliomas: present and future challenges. Transl Med UniSa. 2014;10:29–37.PubMedPubMedCentral

Bhatt AN, Mathur R, Farooque A, Verma A, Dwarakanath BS. Cancer biomarkers—current perspectives. Indian J Med Res. 2010;132:129–49.PubMed

Cho WC. Contribution of oncoproteomics to cancer biomarker discovery. Mol Cancer. 2007;6:25. doi:10.1186/1476-4598-6-25.CrossRefPubMedPubMedCentral

Bleeker FE, Molenaar RJ, Leenstra S. Recent advances in the molecular understanding of glioblastoma. J Neuro-Oncol. 2012;108:11–27. doi:10.1007/s11060-011-0793-0.CrossRef

Sun Y, Zhang W, Chen D, Lv Y, Zheng J, Lilljebjorn H, et al. A glioma classification scheme based on coexpression modules of EGFR and PDGFRA. Proc Natl Acad Sci U S A. 2014;111:3538–43. doi:10.1073/pnas.1313814111.CrossRefPubMedPubMedCentral

Resnier P, David S, Lautram N, Delcroix GJ, Clavreul A, Benoit JP, et al. EGFR siRNA lipid nanocapsules efficiently transfect glioma cells in vitro. Int J Pharm. 2013;454:748–55. doi:10.1016/j.ijpharm.2013.04.001.CrossRefPubMed

Paul I, Bhattacharya S, Chatterjee A, Ghosh MK. Current understanding on EGFR and Wnt/beta-catenin signaling in glioma and their possible crosstalk. Genes Cancer. 2013;4:427–46. doi:10.1177/1947601913503341.CrossRefPubMedPubMedCentral

Hua W, Yao Y, Chu Y, Zhong P, Sheng X, Xiao B, et al. The CD133+ tumor stem-like cell-associated antigen may elicit highly intense immune responses against human malignant glioma. J Neuro-Oncol. 2011;105:149–57. doi:10.1007/s11060-011-0572-y.CrossRef

10.

Liu J, Xu X, Feng X, Zhang B, Wang J. Adenovirus-mediated delivery of bFGF small interfering RNA reduces STAT3 phosphorylation and induces the depolarization of mitochondria and apoptosis in glioma cells U251. J Exp Clin Cancer Res. 2011;30:80. doi:10.1186/1756-9966-30-80.CrossRefPubMedPubMedCentral

11.

Zhang B, Feng X, Wang J, Xu X, Lin N, Liu H. Combined antitumor effect of ad-bFGF-siRNA and ad-Vpr on the growth of xenograft glioma in nude mouse model. Pathol Oncol Res. 2011;17:237–42. doi:10.1007/s12253-010-9303-5.CrossRefPubMed

12.

Zhou Y, Jin G, Mi R, Dong C, Zhang J, Liu F. The methylation status of the platelet-derived growth factor-B gene promoter and its regulation of cellular proliferation following folate treatment in human glioma cells. Brain Res. 2014;1556:57–66. doi:10.1016/j.brainres.2014.01.045.CrossRefPubMed

13.

Liu KW, Hu B, Cheng SY. Platelet-derived growth factor receptor alpha in glioma: a bad seed. Chin J Cancer. 2011;30:590–602. doi:10.5732/cjc.011.10236.CrossRefPubMedPubMedCentral

14.

Liang C, Guo S, Yang L. Effects of alltrans retinoic acid on VEGF and HIF1alpha expression in glioma cells under normoxia and hypoxia and its antiangiogenic effect in an intracerebral glioma model. Mol Med Rep. 2014;10:2713–9. doi:10.3892/mmr.2014.2543.PubMed

15.

Li D, Li XP, Wang HX, Shen QY, Li XP, Wen L, et al. VEGF induces angiogenesis in a zebrafish embryo glioma model established by transplantation of human glioma cells. Oncol Rep. 2012;28:937–42. doi:10.3892/or.2012.1861.PubMed

16.

Sinha S, Koul N, Dixit D, Sharma V, Sen E. IGF-1 induced HIF-1alpha-TLR9 cross talk regulates inflammatory responses in glioma. Cell Signal. 2011;23:1869–75. doi:10.1016/j.cellsig.2011.06.024.CrossRefPubMed

17.

Hsieh A, Ellsworth R, Hsieh D. Hedgehog/GLI1 regulates IGF dependent malignant behaviors in glioma stem cells. J Cell Physiol. 2011;226:1118–27. doi:10.1002/jcp.22433.CrossRefPubMed

18.

Drukala J, Urbanska K, Wilk A, Grabacka M, Wybieralska E, Del Valle L, et al. ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARalpha -mediated inhibition of glioma cell motility in vitro. Mol Cancer. 2010;9:159. doi:10.1186/1476-4598-9-159.CrossRefPubMedPubMedCentral

19.

Acharya S, Chatterjee S, Kumar P, Bhattacharjee M, Chaudhuri S, Chaudhuri S. Induction of G1 arrest in glioma cells by T11TS is associated with upregulation of Cip1/Kip1 and concurrent downregulation of cyclin D (1 and 3. Anti-Cancer Drugs. 2010;21:53–64. doi:10.1097/CAD.0b013e32833276e8.CrossRefPubMed

20.

Sun YC, Wang J, Guo CC, Sai K, Wang J, Chen FR, et al. MiR-181b sensitizes glioma cells to teniposide by targeting MDM2. BMC Cancer. 2014;14:611. doi:10.1186/1471-2407-14-611.CrossRefPubMedPubMedCentral

21.

Wang H, Yuan Z, Chen Z, Yao F, Hu Z, Wu B. Effect of quercetin on glioma cell U87 apoptosis and feedback regulation of MDM2-p53. Nan Fang Yi Ke Da Xue Xue Bao. 2014;34:686–9.PubMed

22.

Barton KL, Misuraca K, Cordero F, Dobrikova E, Min HD, Gromeier M, et al. PD-0332991, a CDK4/6 inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem glioma. PLoS One. 2013;8:e77639. doi:10.1371/journal.pone.0077639.CrossRefPubMedPubMedCentral

23.

Kumar S. P53 induction accompanying G2/M arrest upon knockdown of tumor suppressor HIC1 in U87MG glioma cells. Mol Cell Biochem. 2014;395:281–90. doi:10.1007/s11010-014-2137-9.CrossRefPubMed

24.

Robertson LB, Armstrong GN, Olver BD, Lloyd AL, Shete S, Lau C, et al. Survey of familial glioma and role of germline p16INK4A/p14ARF and p53 mutation. Familial Cancer. 2010;9:413–21. doi:10.1007/s10689-010-9346-5.CrossRefPubMedPubMedCentral

25.

Tachibana I, Smith JS, Sato K, Hosek SM, Kimmel DW, Jenkins RB. Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma. Am J Med Genet. 2000;92:136–41.CrossRefPubMed

26.

Ishii N, Maier D, Merlo A, Tada M, Sawamura Y, Diserens AC, et al. Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol. 1999;9:469–79.CrossRefPubMed

27.

Palani M, Devan S, Arunkumar R, Vanisree AJ. Frequency variations in the methylated pattern of p73/p21 genes and chromosomal aberrations correlating with different grades of glioma among south Indian population. Med Oncol. 2011;28:S445–52. doi:10.1007/s12032-010-9671-4.CrossRefPubMed

28.

Wang MH, Lin CL, Zhang JJ, Weng ZP, Hu T, Xie Q, et al. Role of PTEN in cholera toxin-induced SWO38 glioma cell differentiation. Mol Med Rep. 2013;7:1912–8. doi:10.3892/mmr.2013.1434.PubMed

29.

Errafiy R, Aguado C, Ghislat G, Esteve JM, Gil A, Loutfi M, et al. PTEN increases autophagy and inhibits the ubiquitin-proteasome pathway in glioma cells independently of its lipid phosphatase activity. PLoS One. 2013;8:e83318. doi:10.1371/journal.pone.0083318.CrossRefPubMedPubMedCentral

30.

Fueyo J, Gomez-Manzano C, Alemany R, Lee PS, McDonnell TJ, Mitlianga P, et al. A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo. Oncogene. 2000;19:2–12. doi:10.1038/sj.onc.1203251.CrossRefPubMed

31.

Mitlianga PG, Gomez-Manzano C, Kyritsis AP, Fueyo J. Overexpression of E2F-1 leads to bax-independent cell death in human glioma cells. Int J Oncol. 2002;21:1015–20.PubMed

32.

Gomez-Manzano C, Lemoine MG, Hu M, He J, Mitlianga P, Liu TJ, et al. Adenovirally-mediated transfer of E2F-1 potentiates chemosensitivity of human glioma cells to temozolomide and BCNU. Int J Oncol. 2001;19:359–65.PubMed

33.

Maruyama R, Suzuki H. Long noncoding RNA involvement in cancer. BMB Rep. 2012;45:604–11.CrossRefPubMedPubMedCentral

34.

Yan B, Wang ZH, Guo JT. The research strategies for probing the function of long noncoding RNAs. Genomics. 2012;99:76–80. doi:10.1016/j.ygeno.2011.12.002.CrossRefPubMed

35.

Nakagawa S, Kageyama Y. Nuclear lncRNAs as epigenetic regulators-beyond skepticism. Biochim Biophys Acta. 2014;1839:215–22. doi:10.1016/j.bbagrm.2013.10.009.CrossRefPubMed

36.

Mattick JS. Non-coding RNAs: the architects of eukaryotic complexity. EMBO Rep. 2001;2:986–91. doi:10.1093/embo-reports/kve230.CrossRefPubMedPubMedCentral

37.

Lee C, Kikyo N. Strategies to identify long noncoding RNAs involved in gene regulation. Cell Biosci. 2012;2:37. doi:10.1186/2045-3701-2-37.CrossRefPubMedPubMedCentral

38.

Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012;22:1775–89. doi:10.1101/gr.132159.111.CrossRefPubMedPubMedCentral

39.

Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136:629–41. doi:10.1016/j.cell.2009.02.006.CrossRefPubMed

40.

Wang X, Song X, Glass CK, Rosenfeld MG. The long arm of long noncoding RNAs: roles as sensors regulating gene transcriptional programs. Cold Spring Harb Perspect Biol. 2011;3:a003756. doi:10.1101/cshperspect.a003756.PubMedPubMedCentral

41.

van Bakel H, Hughes TR. Establishing legitimacy and function in the new transcriptome. Brief Funct Genomic Proteomic. 2009;8:424–36. doi:10.1093/bfgp/elp037.CrossRefPubMed

42.

Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, Willingham AT, et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science. 2007;316:1484–8. doi:10.1126/science.1138341.CrossRefPubMed

43.

Spizzo R, Almeida MI, Colombatti A, Calin GA. Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene. 2012;31:4577–87. doi:10.1038/onc.2011.621.CrossRefPubMedPubMedCentral

44.

Han L, Zhang K, Shi Z, Zhang J, Zhu J, Zhu S, et al. LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis. Int J Oncol. 2012;(40):2004–12. doi:10.3892/ijo.2012.1413.

45.

Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464:1071–6. doi:10.1038/nature08975.CrossRefPubMedPubMedCentral

46.

Zhang JX, Han L, Bao ZS, Wang YY, Chen LY, Yan W, et al. HOTAIR, a cell cycle-associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma. Neuro Oncol. 2013;(15):1595–603. doi:10.1093/neuonc/not131.

47.

Pastori C, Kapranov P, Penas C, Peschansky V, Volmar CH, Sarkaria JN, et al. The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation. Proc Natl Acad Sci U S A. 2015;112:8326–31. doi:10.1073/pnas.1424220112.CrossRefPubMedPubMedCentral

48.

Ke J, Yao YL, Zheng J, Wang P, Liu YH, Ma J, et al. Knockdown of long non-coding RNA HOTAIR inhibits malignant biological behaviors of human glioma cells via modulation of miR-326. Oncotarget. 2015;6:21934–49. doi:10.18632/oncotarget.4290.CrossRefPubMedPubMedCentral

49.

Cai X, Cullen BR. The imprinted H19 noncoding RNA is a primary microRNA precursor. RNA. 2007;13:313–6. doi:10.1261/rna.351707.CrossRefPubMedPubMedCentral

50.

Ariel I, de Groot N, Hochberg A. Imprinted H19 gene expression in embryogenesis and human cancer: the oncofetal connection. Am J Med Genet. 2000;91:46–50.CrossRefPubMed

51.

Gabory A, Jammes H, Dandolo L. The H19 locus: role of an imprinted non-coding RNA in growth and development. BioEssays. 2010;32:473–80. doi:10.1002/bies.200900170.CrossRefPubMed

52.

Ariel I, Sughayer M, Fellig Y, Pizov G, Ayesh S, Podeh D, et al. The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma. Mol Pathol. 2000;53:320–3.CrossRefPubMedPubMedCentral

53.

Berteaux N, Lottin S, Monte D, Pinte S, Quatannens B, Coll J, et al. H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J Biol Chem. 2005;280:29625–36. doi:10.1074/jbc.M504033200.CrossRefPubMed

54.

Shi Y, Wang Y, Luan W, Wang P, Tao T, Zhang J, et al. Long non-coding RNA H19 promotes glioma cell invasion by deriving miR-675. PLoS One. 2014;9:e86295. doi:10.1371/journal.pone.0086295.CrossRefPubMedPubMedCentral

55.

Li C, Lei B, Huang S, Zheng M, Liu Z, Li Z, et al. H19 derived microRNA-675 regulates cell proliferation and migration through CDK6 in glioma. Am J Transl Res. 2015;7:1747–64.PubMedPubMedCentral

56.

Yoon JW, Kita Y, Frank DJ, Majewski RR, Konicek BA, Nobrega MA, et al. Gene expression profiling leads to identification of GLI1-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation. J Biol Chem. 2002;277:5548–55. doi:10.1074/jbc.M105708200.CrossRefPubMed

57.

Xu HS, Zong HL, Shang M, Ming X, Zhao JP, Ma C, et al. MiR-324-5p inhibits proliferation of glioma by target regulation of GLI1. Eur Rev Med Pharmacol Sci. 2014;18:828–32.PubMed

58.

Ellis BC, Molloy PL, Graham LD. CRNDE: a long non-coding RNA involved in CanceR, neurobiology, and DEvelopment. Front Genet. 2012;3:270. doi:10.3389/fgene.2012.00270.CrossRefPubMedPubMedCentral

59.

Zhang X, Sun S, JK P, Tsang AC, Lee D, Man VO, et al. Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol Dis. 2012;48:1–8. doi:10.1016/j.nbd.2012.06.004.CrossRefPubMed

60.

Mizoguchi M, Yoshimoto K, Ma X, Guan Y, Hata N, Amano T, et al. Molecular characteristics of glioblastoma with 1p/19q co-deletion. Brain Tumor Pathol. 2012;29:148–53. doi:10.1007/s10014-012-0107-z.CrossRefPubMed

61.

Wang Y, Wang Y, Li J, Zhang Y, Yin H, Han B. CRNDE a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling. Cancer Lett. 2015;367:122–8. doi:10.1016/j.canlet.2015.03.027.CrossRefPubMed

62.

Han Y, Zhou L, Wu T, Huang Y, Cheng Z, Li X, et al. Downregulation of lncRNA-MALAT1 affects proliferation and the expression of Stemness markers in glioma stem cell line SHG139S. Cell Mol Neurobiol. 2015. doi:10.1007/s10571-015-0303-6.

63.

Ma J, Wang P, Yao Y, Liu Y, Li Z, Liu X, et al. Knockdown of long non-coding RNA MALAT1 increases the blood-tumor barrier permeability by up-regulating miR-140. Biochim Biophys Acta. 2016;1859:324–38. doi:10.1016/j.bbagrm.2015.11.008.CrossRefPubMed

64.

He C, Jiang B, Ma J, Li Q. Aberrant NEAT1 expression is associated with clinical outcome in high grade glioma patients. APMIS. 2016;124:169–74. doi:10.1111/apm.12480.CrossRefPubMed

65.

Zhen L, Yun-Hui L, Hong-Yu D, Jun M, Yi-Long Y. Long noncoding RNA NEAT1 promotes glioma pathogenesis by regulating miR-449b-5p/c-met axis. Tumour Biol. 2016;37:673–83. doi:10.1007/s13277-015-3843-y.CrossRefPubMed

66.

Wang Q, Zhang J, Liu Y, Zhang W, Zhou J, Duan R, et al. A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma. Cancer Lett. 2016;373:251–9. doi:10.1016/j.canlet.2016.01.039.CrossRefPubMed

67.

Guo H, Wu L, Yang Q, Ye M, Zhu X. Functional linc-POU3F3 is overexpressed and contributes to tumorigenesis in glioma. Gene. 2015;554:114–9. doi:10.1016/j.gene.2014.10.038.CrossRefPubMed

68.

Zhu Y, Zhang X, Qi L, Cai Y, Yang P, Xuan G, et al. HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling pathway in human gliomas. Oncotarget. 2016. doi:10.18632/oncotarget.7418.

69.

Liu H, Lv Z, Guo E. Knockdown of long noncoding RNA SPRY4-IT1 suppresses glioma cell proliferation, metastasis and epithelial-mesenchymal transition. Int J Clin Exp Pathol. 2015;8:9140–6.PubMedPubMedCentral

70.

Ma CC, Xiong Z, Zhu GN, Wang C, Zong G, Wang HL, et al. Long non-coding RNA ATB promotes glioma malignancy by negatively regulating miR-200a. J Exp Clin Cancer Res. 2016;35:–90. doi:10.1186/s13046-016-0367-2.

71.

Hu L, Lv QL, Chen SH, Sun B, Qu Q, Cheng L, et al. Up-regulation of long non-coding RNA AB073614 predicts a poor prognosis in patients with glioma. Int J Environ Res Public Health. 2016:13. doi:10.3390/ijerph13040433.

72.

Miyoshi N, Wagatsuma H, Wakana S, Shiroishi T, Nomura M, Aisaka K, et al. Identification of an imprinted gene, Meg3/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q. Genes Cells. 2000;5:211–20.CrossRefPubMed

73.

Zhang X, Rice K, Wang Y, Chen W, Zhong Y, Nakayama Y, et al. Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions. Endocrinology. 2010;151:939–47. doi:10.1210/en.2009-0657.CrossRefPubMed

74.

Wang P, Ren Z, Sun P. Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation. J Cell Biochem. 2012;113:1868–74. doi:10.1002/jcb.24055.CrossRefPubMed

75.

Li J, Bian EB, He XJ, Ma CC, Zong G, Wang HL, et al. Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas. Int J Oncol. 2016;48:723–33. doi:10.3892/ijo.2015.3285.PubMed

76.

Yao Y, Ma J, Xue Y, Wang P, Li Z, Liu J, et al. Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152. Cancer Lett. 2015;359:75–86. doi:10.1016/j.canlet.2014.12.051.CrossRefPubMed

77.

Qin X, Yao J, Geng P, Fu X, Xue J, Zhang Z. LncRNA TSLC1-AS1 is a novel tumor suppressor in glioma. Int J Clin Exp Pathol. 2014;7:3065–72.PubMedPubMedCentral

78.

Yao J, Zhou B, Zhang J, Geng P, Liu K, Zhu Y, et al. A new tumor suppressor LncRNA ADAMTS9-AS2 is regulated by DNMT1 and inhibits migration of glioma cells. Tumour Biol. 2014;35:7935–44. doi:10.1007/s13277-014-1949-2.CrossRefPubMed

79.

Yue H, Zhu J, Xie S, Li F, Xu Q. MDC1-AS, an antisense long noncoding RNA, regulates cell proliferation of glioma. Biomed Pharmacother. 2016;81:203–9. doi:10.1016/j.biopha.2016.03.002.

80.

Li J, Zhang M. An G, Ma Q. LncRNA TUG1 acts as a tumor suppressor in human glioma by promoting cell apoptosis. Exp Biol Med (Maywood). 2016;241:644–9. doi:10.1177/1535370215622708.CrossRef

81.

Cai H, Xue Y, Wang P, Wang Z, Li Z, Hu Y, et al. The long noncoding RNA TUG1 regulates blood-tumor barrier permeability by targeting miR-144. Oncotarget. 2015;6:19759–79. doi:10.18632/oncotarget.4331.CrossRefPubMedPubMedCentral

82.

Feng S, Yao J, Chen Y, Geng P, Zhang H, Ma X, et al. Expression and functional role of reprogramming-related long noncoding RNA (lincRNA-ROR) in glioma. J Mol Neurosci. 2015;56:623–30. doi:10.1007/s12031-014-0488-z.CrossRefPubMed

83.

Zhao X, Wang P, Liu J, Zheng J, Liu Y, Chen J, et al. Gas5 exerts tumor-suppressive functions in human glioma cells by targeting miR-222. Mol Ther. 2015;23:1899–911. doi:10.1038/mt.2015.170.CrossRefPubMed

84.

Wang P, Liu YH, Yao YL, Li Z, Li ZQ, Ma J, et al. Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21. Cell Signal. 2015;27:275–82. doi:10.1016/j.cellsig.2014.11.011.CrossRefPubMed

85.

Weirick T, John D, Dimmeler S, Uchida S. C-it-loci: a knowledge database for tissue-enriched loci. Bioinformatics. 2015;31:3537–43. doi:10.1093/bioinformatics/btv410.CrossRefPubMed

86.

Zhao Z, Bai J, Wu A, Wang Y, Zhang J, Wang Z, et al. Co-LncRNA: investigating the lncRNA combinatorial effects in GO annotations and KEGG pathways based on human RNA-seq data. Database (Oxford). 2015. doi:10.1093/database/bav082.

87.

Yang JH, Li JH, Jiang S, Zhou H, Qu LH. ChIPBase: a database for decoding the transcriptional regulation of long non-coding RNA and microRNA genes from ChIP-seq data. Nucleic Acids Res. 2013;41:D177–87. doi:10.1093/nar/gks1060.CrossRefPubMed

88.

Liu C, Bai B, Skogerbo G, Cai L, Deng W, Zhang Y, et al. NONCODE: an integrated knowledge database of non-coding RNAs. Nucleic Acids Res. 2005;33:D112–5. doi:10.1093/nar/gki041.CrossRefPubMed

89.

Zhao Y, Li H, Fang S, Kang Y, Wu W, Hao Y, et al. NONCODE 2016: an informative and valuable data source of long non-coding RNAs. Nucleic Acids Res. 2016;44:D203–8. doi:10.1093/nar/gkv1252.CrossRefPubMed

90.

Chakraborty S, Deb A, Maji RK, Saha S, Ghosh Z. LncRBase: an enriched resource for lncRNA information. PLoS One. 2014;9:e108010. doi:10.1371/journal.pone.0108010.CrossRefPubMedPubMedCentral

91.

Amaral PP, Clark MB, Gascoigne DK, Dinger ME, Mattick JS. lncRNAdb: a reference database for long noncoding RNAs. Nucleic Acids Res. 2011;39:D146–51. doi:10.1093/nar/gkq1138.CrossRefPubMed

92.

Quek XC, Thomson DW, Maag JL, Bartonicek N, Signal B, Clark MB, et al. lncRNAdb v2.0: expanding the reference database for functional long noncoding RNAs. Nucleic Acids Res. 2015;43:D168–73. doi:10.1093/nar/gku988.CrossRefPubMed

93.

Bhartiya D, Pal K, Ghosh S, Kapoor S, Jalali S, Panwar B, et al. lncRNome: a comprehensive knowledgebase of human long noncoding RNAs. Database (Oxford). 2013;2013:bat034. doi:10.1093/database/bat034.CrossRef

94.

Yang JH, Li JH, Shao P, Zhou H, Chen YQ, Qu LH. starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-seq and Degradome-seq data. Nucleic Acids Res. 2011;39:D202–9. doi:10.1093/nar/gkq1056.CrossRefPubMed

95.

Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-seq data. Nucleic Acids Res. 2014;42:D92–7. doi:10.1093/nar/gkt1248.CrossRefPubMed

96.

Volders PJ, Helsens K, Wang X, Menten B, Martens L, Gevaert K, et al. LNCipedia: a database for annotated human lncRNA transcript sequences and structures. Nucleic Acids Res. 2013;41:D246–51. doi:10.1093/nar/gks915.CrossRefPubMed

97.

Volders PJ, Verheggen K, Menschaert G, Vandepoele K, Martens L, Vandesompele J, et al. An update on LNCipedia: a database for annotated human lncRNA sequences. Nucleic Acids Res. 2015;43:4363–4. doi:10.1093/nar/gkv295.CrossRefPubMedPubMedCentral

98.

Jiang Q, Ma R, Wang J, Wu X, Jin S, Peng J, et al. LncRNA2Function: a comprehensive resource for functional investigation of human lncRNAs based on RNA-seq data. BMC Genomics. 2015;16:S2. doi:10.1186/1471-2164-16-s3-s2.CrossRefPubMedPubMedCentral

99.

Gong J, Liu W, Zhang J, Miao X, Guo AY. lncRNASNP: a database of SNPs in lncRNAs and their potential functions in human and mouse. Nucleic Acids Res. 2015;43:D181–6. doi:10.1093/nar/gku1000.CrossRefPubMed

100.

Chen G, Wang Z, Wang D, Qiu C, Liu M, Chen X, et al. LncRNADisease: a database for long-non-coding RNA-associated diseases. Nucleic Acids Res. 2013;41:D983–6. doi:10.1093/nar/gks1099.CrossRefPubMed

101.

Ning S, Zhang J, Wang P, Zhi H, Wang J, Liu Y, et al. Lnc2Cancer: a manually curated database of experimentally supported lncRNAs associated with various human cancers. Nucleic Acids Res. 2016;44:D980–5. doi:10.1093/nar/gkv1094.CrossRefPubMed

102.

Liu K, Yan Z, Li Y, Sun Z. Linc2GO: a human lncRNA function annotation resource based on ceRNA hypothesis. Bioinformatics. 2013;29:2221. doi:10.1093/bioinformatics/btt361.

103.

Jeggari A, Marks DS, Larsson E. miRcode: a map of putative microRNA target sites in the long non-coding transcriptome. Bioinformatics. 2012;28:2062–3. doi:10.1093/bioinformatics/bts344.CrossRefPubMedPubMedCentral

104.

Paraskevopoulou MD, Georgakilas G, Kostoulas N, Reczko M, Maragkakis M, Dalamagas TM, et al. DIANA-lncBase: experimentally verified and computationally predicted microRNA targets on long non-coding RNAs. Nucleic Acids Res. 2013;41:D239–45. doi:10.1093/nar/gks1246.CrossRefPubMed

105.

Paraskevopoulou MD, Vlachos IS, Karagkouni D, Georgakilas G, Kanellos I, Vergoulis T, et al. DIANA-lncBase v2: indexing microRNA targets on non-coding transcripts. Nucleic Acids Res. 2016;44:D231–8. doi:10.1093/nar/gkv1270.CrossRefPubMed

106.

Wang P, Ning S, Zhang Y, Li R, Ye J, Zhao Z, et al. Identification of lncRNA-associated competing triplets reveals global patterns and prognostic markers for cancer. Nucleic Acids Res. 2015;43:3478–89. doi:10.1093/nar/gkv233.CrossRefPubMedPubMedCentral

107.

Chang TH, Huang HY, Hsu JB, Weng SL, Horng JT, Huang HD. An enhanced computational platform for investigating the roles of regulatory RNA and for identifying functional RNA motifs. BMC Bioinforma. 2013;(14):S4. doi:10.1186/1471-2105-14-s2-s4.

Titel: A critical overview of long non-coding RNA in glioma etiology 2016: an update
verfasst von: Yuan-Feng Gao
Zhi-Bin Wang
Tao Zhu
Chen-Xue Mao
Xiao-Yuan Mao
Ling Li
Ji-Ye Yin
Hong-Hao Zhou
Zhao-Qian Liu
Publikationsdatum: 15.09.2016
Verlag: Springer Netherlands
Erschienen in: Tumor Biology / Ausgabe 11/2016
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-016-5307-4

Neu im Fachgebiet Onkologie

24.04.2024 | DGIM 2024 | Nachrichten

Springer Medizin

A critical overview of long non-coding RNA in glioma etiology 2016: an update

Abstract

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2016

The predictive potential and oncogenic effects of HOXC8 expression on osteosarcoma

MicroRNA-490 regulates lung cancer metastasis by targeting poly r(C)-binding protein 1

Role of miRNA dynamics and cytokine profile in governing CD44v6/Nanog/PTEN axis in oral cancer: modulating the master regulators

Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity

Apoptotic effect of the selective PPARβ/δ agonist GW501516 in invasive bladder cancer cells

The anticancer effects of Resina Draconis extract on cholangiocarcinoma

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie